DelveInsight's 'IGALMI Market Size, Forecast, and Market Insight Report' highlights the details around IGALMI, a sublingual film formulation ...

DelveInsight’s “Ulcerative Colitis Market Insights, Epidemiology and Market Forecast – 2034” report delivers an in-depth ...

Johnson & Johnson has started 2025 better than I expected, even with the long-running talc saga. Find out why I remain ...

Recursion Pharmaceuticals, Inc.’s RXRX share price has surged by 7.02%, which has investors questioning if this is right time ...

With increasing global diagnosis rates and expanding access in emerging markets, HEMLIBRA is poised for continued growth.

But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies ... but the above data ...

Last year, Takeda firmly cemented its place in the emerging markets when it acquired Swiss pharma company, Nycomed, for US $13.7bn. According to a recent report, Russia’s pharmaceutical market ...

From joint ventures to licensing deals, biotechnology is emerging as a strategic bridge between China and Japan.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

The business: Tursio helps workers use AI to quickly analyze their structured data. The company recently launched the first version of its product for the enterprise market, with a focus on ...